Connection Between CDC20 Expression and Hepatocellular Carcinoma Prognosis

31 March 2021 : Laboratory Research

Xianfeng Zhang^1A, Xianjun Zhang^2B, Xinguo Li^1C, Hongbing Bao^1D, Guang Li^1E, Ning Li^1F, Hengli Li^1F*, Jian Dou^3G

DOI: 10.12659/MSM.926760

Med Sci Monit 2021; 27:e926760

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 2 Univariable and multivariate Cox regression analyses for CDC20 in HCC patients.

Characteristics	Univariate analysis		Multivariate analysis
Characteristics	HR (95%CI)	P-value	HR (95%CI)	P-value
	2.464 (1.245–4.876)	0.010^*	2.354 (1.177–4.709)	0.016^*
Age	0.670 (0.369–1.219)	0.190	–	–
Sex	0.834 (0.460–1.512)	0.550	–	–
Tumor size	0.863 (0.474–1.573)	0.631	–	–
Differentiation	1.930 (1.007–3.700)	0.048^*	–	–
TNM stage	1.304 (0.689–2.469)	0.415	–	–
Lymphatic metastasis	1.944 (1.049–3.602)	0.035^*
HCC – hepatocellular carcinoma; HR – hazard ratio; CI – confidence interval; TNM – tumor node metastasis. ^* Statistically significant.

Back to the Article